The STING protein, known for helping cells fight viral infections by generating inflammation, also appears to function as a ...

Parkinson's disease is the second most common neurodegenerative disease in the world... | Genetics And Genomics ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

During the endosome–lysosome transition, the compartmental pH drops, which is conducive to the function of lysosomal acid hydrolases. Here the authors show that the biological fate of rare earth ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of ...